Cargando…
1951. Guiding COVID-19 Booster Vaccinations by COVID-19 Quantitative Spike Ig Antibody Titers Regardless of HIV Status, Immunosuppression, and Age
BACKGROUND: In-vitro neutralizing antibody (Ab) titers correlated with ∼250 IU/mL Spike Ig Ab level for the Delta COVID-19 variant, establishing the 2021 French and Swiss cutoff for booster guidance. In a New York City healthcare clinic where those guidelines were adopted, we aimed to quantify vacci...
Autores principales: | Hsu, Ricky K, Brunet, Laurence, Fusco, Jennifer S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752935/ http://dx.doi.org/10.1093/ofid/ofac492.1578 |
Ejemplares similares
-
Adjusted COVID-19 booster schedules balance age-dependent differences in antibody titers benefitting risk populations
por: Müller, Lisa, et al.
Publicado: (2022) -
COVID-19 outcome is not affected by anti-CD20 or high-titer convalescent plasma in immunosuppressed patients
por: Kasten, Mary J., et al.
Publicado: (2023) -
Coronavirus Disease 2019-Related Alterations of Total and Anti-Spike IgG Glycosylation in Relation to Age and Anti-Spike IgG Titer
por: Schwedler, Christian, et al.
Publicado: (2022) -
The Antibody Response to the BNT162b2 mRNA COVID-19 Booster in Healthcare Workers: Association between the IgG Antibody Titers and Anthropometric and Body Composition Parameters
por: Golec, Marlena, et al.
Publicado: (2022) -
POS-925 FACTORS PREDICTIVE OF ANTI-SPIKE ANTIBODIES TITERS AFTER COVID-19 VACCINATION IN HEMODIALYSIS PATIENTS
por: AOUN, M., et al.
Publicado: (2022)